Ro-24-6392

N/A

Report date: 2026/03/06 20:02:51

NME

Base Information

Drug NameRo-24-6392

Drug Alias NameRo-24-6392

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionCell wall inhibitorsBacterial DNA gyrase inhibitors

TargetsBacterial DNA gyrase

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesClinical Microbiology Institute Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesClinical Microbiology Institute Inc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A